Genetron Holdings Ltd. ADR (GTH): Price and Financial Metrics Recent IPO

Genetron Holdings Ltd. ADR (GTH) Recent IPO

Today's Latest Price: $13.94 USD

0.26 (1.90%)

Updated Dec 1 6:55pm

Add GTH to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

GTH Stock Price Chart Interactive Chart >

Price chart for GTH

GTH Price/Volume Stats

Current price $13.94 52-week high $17.71
Prev. close $13.68 52-week low $9.03
Day low $13.48 Volume 196,300
Day high $14.02 Avg. volume 295,898
50-day MA $11.34 Dividend yield N/A
200-day MA $0.00 Market Cap 1.23B

Genetron Holdings Ltd. ADR (GTH) Company Bio

Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China.

GTH Latest News Stream

Event/Time News Detail
Loading, please wait...

GTH Latest Social Stream

Loading social stream, please wait...

View Full GTH Social Stream

Latest GTH News From Around the Web

Below are the latest news stories about Genetron Holdings Ltd that investors may wish to consider to help them evaluate GTH as an investment opportunity.

Genetron Holdings EPS beats by $0.06, beats on revenue

Genetron Holdings (GTH): Q2 Non-GAAP EPS of -$0.04 beats by $0.06; GAAP EPS of -$2.41 misses by $2.32.Revenue of $14.4M beats by $1.21M.Press Release...

Seeking Alpha | August 6, 2020

Genetron prices upsized IPO at $16, trading kicks off today

Genetron Holdings Limited (GTH) prices its IPO of 16.0M (from 13.0M) American Depositary Shares (ADSs), each representing five ordinary shares, at $16.00 per ADS.Underwriters' over-allotment is an additional 2.4M ADSs.The Beijing-based company provides next-gen sequencing ((NGS))-based molecular testing services in oncology.Trading on the Nasdaq Global Market commences today.2019 Financials: Revenue:...

Seeking Alpha | June 19, 2020

Read More 'GTH' Stories Here

GTH Price Returns

1-mo 45.06%
3-mo 15.68%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.1495 seconds.